ストックスクリーナーアプリを入手
27.87
6.27%
1.7199
前日終値:
$26.15
開ける：
$26.19
24時間の取引高:
17.25M
Relative Volume:
0.52
時価総額：
$6.45B
収益：
$2.35B
当期純損益:
$128.37M
株価収益率:
53.38
EPS:
0.5221
ネットキャッシュフロー:
$57.42M
1週間 パフォーマンス:
+17.01%
1か月 パフォーマンス:
+1.38%
6か月 パフォーマンス:
-25.92%
1年 パフォーマンス:
-50.87%
1日の値動き範囲:
$25.50
$28.22
1週間の範囲:
$23.36
$28.22
52週間の値動き範囲:
$13.74
$70.43
Hims Hers Health Inc Stock (HIMS) Company Profile
Compare HIMS vs TAK, TEVA, HLN, ZTS, UTHR
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
27.87 | 6.05B | 2.35B | 128.37M | 57.42M | 0.5221 |
TAK
Takeda Pharmaceutical Co Adr
|
15.23 | 50.43B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.64 | 41.13B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
8.84 | 40.12B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
77.67 | 32.57B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
545.57 | 23.64B | 3.17B | 1.29B | 1.01B | 27.09 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-24 | 開始されました | JP Morgan | Overweight |
| 2026-03-10 | アップグレード | BofA Securities | Underperform → Neutral |
| 2026-03-10 | アップグレード | Citigroup | Sell → Neutral |
| 2026-03-09 | アップグレード | Needham | Hold → Buy |
| 2026-02-24 | ダウングレード | BTIG Research | Buy → Neutral |
| 2026-01-12 | 開始されました | Evercore ISI | In-line |
| 2025-12-09 | 開始されました | Barclays | Overweight |
| 2025-10-21 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2025-06-23 | ダウングレード | Needham | Buy → Hold |
| 2025-06-04 | 繰り返されました | Needham | Buy |
| 2025-04-29 | ダウングレード | TD Cowen | Buy → Hold |
| 2025-02-18 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-10 | ダウングレード | Citigroup | Neutral → Sell |
| 2025-01-07 | 開始されました | BTIG Research | Buy |
| 2024-12-17 | 開始されました | Morgan Stanley | Overweight |
| 2024-11-14 | ダウングレード | BofA Securities | Buy → Underperform |
| 2024-08-22 | 開始されました | Needham | Buy |
| 2024-08-09 | ダウングレード | Imperial Capital | Outperform → In-line |
| 2024-05-22 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-04-16 | ダウングレード | Jefferies | Buy → Hold |
| 2024-04-10 | 開始されました | Canaccord Genuity | Buy |
| 2024-02-28 | アップグレード | Imperial Capital | In-line → Outperform |
| 2024-02-26 | 開始されました | Leerink Partners | Market Perform |
| 2023-12-07 | 開始されました | Imperial Capital | In-line |
| 2023-07-28 | 開始されました | TD Cowen | Outperform |
| 2023-04-11 | 開始されました | Robert W. Baird | Neutral |
| 2023-02-09 | アップグレード | Jefferies | Hold → Buy |
| 2022-11-08 | アップグレード | BofA Securities | Neutral → Buy |
| 2022-11-08 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | 開始されました | Truist | Hold |
| 2022-07-15 | 開始されました | SVB Leerink | Underperform |
| 2022-04-14 | 開始されました | Guggenheim | Buy |
| 2022-04-01 | 再開されました | Credit Suisse | Outperform |
| 2022-03-10 | 開始されました | Deutsche Bank | Hold |
| 2021-12-02 | 開始されました | Jefferies | Hold |
| 2021-11-11 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | 開始されました | BofA Securities | Neutral |
| 2021-05-20 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | 開始されました | Truist | Hold |
| 2021-03-09 | 開始されました | Credit Suisse | Neutral |
| 2021-03-02 | アップグレード | Citigroup | Neutral → Buy |
| 2021-02-17 | 開始されました | Citigroup | Neutral |
| 2021-02-12 | 開始されました | Piper Sandler | Neutral |
| 2021-02-08 | 開始されました | Tigress Financial | Buy |
すべてを表示
Hims Hers Health Inc (HIMS) 最新ニュース
$Hims & Hers Health (HIMS.US)$ - Moomoo
Lead Independent Director of Hims & Hers Health David Wells Buys 27% More Shares - simplywall.st
HIMS Stock Eyes Breakout Week: Eight New Partners Fuel Push To Build An All-In-One Health Platform - Stocktwits
$Hims & Hers Health (HIMS.US)$ Not bad! About one year plus with HIMs and it never failed me. - Moomoo
$Hims & Hers Health (HIMS.US)$ that’s what I’m talking about $Hims & Hers Health (HIMS.US)$ 📈 - Moomoo
PPI Report April 2026: How Inflation Data Is Moving HIMS, CEG, and PLUG Stock Today - TradingKey
Hims & Hers Health Stock (HIMS) Opinions on technical resistance levels - Quiver Quantitative
HIMS stock eyes breakout week: Eight new partners fuel push to build an all-in-one health platform - MSN
Hims & Hers Health, Inc. Registered Shs A Cert Deposito Arg Repr 0.25 Shs - TradingView
Net income of Hims & Hers Health, Inc. Registered Shs A Cert Deposito Arg Repr 0.25 Shs – BCBA:HIMSC - TradingView
Cost of goods sold of Hims & Hers Health, Inc. Registered Shs A Cert Deposito Arg Repr 0.25 Shs – BCBA:HIMSC - TradingView
Current ratio of Hims & Hers Health, Inc. Registered Shs A Cert Deposito Arg Repr 0.25 Shs – BCBA:HIMSC - TradingView
Telehealth Co. Hims Likely To Get Suicide Suit Trimmed - Law360
Hims & Hers Health Inc. Class A (HIMS) Stock Price | Live Quotes & Charts | NYSE - StocksToTrade
Hims Insider Makes First Stock Purchase Since 2021 Amid Weight-Loss Drug Pivot - Barron's
Hims & Hers Health Options Spot-On: On May 29th, 229.43K Contracts Were Traded, With 1.04 Million Open Interest - Moomoo
Hims & Hers Expands Integrated Health Access via Platform Expansion - The Globe and Mail
Hims And Hers Canadian GLP 1 Push Tests Broader Wellness Subscription Thesis - Yahoo Finance
Hims & Hers Health, Inc.: Target Price Consensus and Analysts Recommendations | HIMS | US4330001060 - marketscreener.com
Flo Health Expands Distribution Through Collaboration With Hims & Hers Benefits - TipRanks
Hims & Hers adds eight partners to subscriber benefits program By Investing.com - Investing.com Australia
Hims & Hers Expands Benefits for Active Subscribers With Eight New Health and Wellness Partners - Business Wire
HIMS Stock Heads For Weekly Loss — But Ex-Netflix CFO Is Buying The Dip Despite BofA’s GLP-1 Warning - Stocktwits
Hims & Hers Health Expands Benefits Program With Eight New Partners - TradingView
Hims & Hers adds eight partners to subscriber benefits program - Investing.com
One Subscription. Ten Ways to Feel Your Best. - Hims & Hers Newsroom
Hims & Hers Debt-Funded Expansion Tests Its Global Telehealth Ambitions - Investing.com
Hims & Hers eyes global growth: Will $1.15B Eucalyptus deal fuel its recovery or dilute shareholders? - MSN
Hims & Hers Eyes Global Growth: Will $1.15B Eucalyptus Deal Fuel Its Recovery or Dilute Shareholders? - MarketBeat
HIMS stock slips overnight: Hims & Hers bulks up debt raise to $350M for Eucalyptus buyout, AI push - MSN
HIMS News | HIMS & HERS HEALTH INC (NYSE:HIMS) - ChartMill
Hims Hers Health Inc (HIMS) 財務データ
収益
当期純利益
現金流量
EPS
1.69%
0.68%
大文字化:
|
ボリューム (24 時間):